Lineage Cell Therapeutics, Inc. Inventory, Finished Goods, Net of Reserves
Lineage Cell Therapeutics, Inc. (LCTX) had Inventory, Finished Goods, Net of Reserves of $1.00 thousand as of 2015-12-31, per its 10-K filed 2016-03-15.
Discontinued › Notes › Inventory
us-gaap:InventoryFinishedGoodsNetOfReserves · last filed 2016-03-15
- 2015-12-31: Inventory, Finished Goods, Net of Reserves $1.00K.
- 2015-09-30: Inventory, Finished Goods, Net of Reserves $247.00K.
- 2015-06-30: Inventory, Finished Goods, Net of Reserves $284.00K.
- 2015-03-31: Inventory, Finished Goods, Net of Reserves $286.51K.
| Period end | Inventory, Finished Goods, Net of Reserves | Inventory, Finished Goods, Net of Reserves as first filed |
|---|---|---|
| 2015-12-31 | $1.00K 10-K · filed 2016-03-15 | |
| 2015-09-30 | $247.00K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $284.00K 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $286.51K 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $266.00K 10-K · filed 2016-03-15 | $253.23K 10-K · filed 2015-03-11 |
| 2014-09-30 | $240.64K 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $245.01K 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $223.66K 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $165.77K 10-K · filed 2015-03-11 | |
| 2013-09-30 | $48.21K 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $51.82K 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $38.51K 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $41.49K 10-K · filed 2014-03-17 | |
| 2012-09-30 | $43.02K 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $41.07K 10-Q · filed 2012-08-09 | |
| 2011-12-31 | $37.10K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |